Spotlight on Samuel Nwosu and Jubilee Tan

Lead biostatistician Samuel Nwosu was featured in the March 17 issue of the ACTIV-6 Site Newsletter, and application developer Jubilee Tan in the March 4 edition. The interviews are republished here with permission of the Duke Clinical Research Institute.

Data Coordinating Center Spotlights

Samuel Nwosu

What is your role on ACTIV-6? 

Provide assistance with data management, create trial summary reports, perform data validations, and help with implementing the trial's interim analyses.

 

What activities or hobbies do you enjoy outside of work? 

I enjoy spending time with my family, a good jog, and the occasional adventurous/extreme activity.

 

Why do you think ACTIV-6 is important? 

This trial is at the forefront to help mitigate the spread of COVID-19 and provide a pathway to ending this global pandemic.

 

What drives and motivates you about working on the ACTIV-6 study? 

Knowing that the work I do is part of a bigger community to assist in the fight against COVID-19. Hopefully my effort within the ACTIV-6 study will help everyone get back to some sense of normalcy

 

Jubilee Tan

What is your role on ACTIV-6?

I maintain and upgrade automated information systems among four roles: participants, pharmacy, the call center, and biometric analysts.

 

What activities or hobbies do you enjoy outside of work?

When I get off work, I usually spend time with family, watch movies, and fix some issues in open source community.

 

Why do you think ACTIV-6 is important?

Since COVID changed our lives two years ago, many families may have faced a very big change, not only the loss of life, but also social distancing and economic shock. This project is an opportunity to turn things around so that people can go back to life before the pandemic.

 

What drives and motivates you about working on the ACTIV-6 study?

This project is about helping people fight COVID, and I feel very motivated every time I think about this work that could lead to an earlier end to the pandemic.

The ACTIV-6 study is reaching out to prospective participants in Spanish as well as English.